Form 8.3

Summary by AI BETAClose X

Qube Research disclosed on 05-11-2026 an opening position in Advanced Medical Solutions: it holds 8,023,169 cash-settled derivatives representing 3.62% economic exposure, while owning 0 (0.00%) ordinary shares and holding 0 stock-settled derivatives or subscription rights; the position was held on 04-11-2026. The filer increased a long position via an equity swap covering 28,392 shares at 283.00 GBp per unit. No indemnities, voting arrangements or open stock-settled positions were declared. The cash-settled nature conveys economic exposure but not voting rights, which may affect liquidity or price if closed without altering current shareholder voting structure.

Disclaimer*

UK 100

Latest directors dealings